Albany Molecular Research Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
223.09 Mil |
| Income |
12.27 Mil |
| Net Profit Margin |
5.50% |
| Return on Equity |
3.71% |
| Debt/Equity Ratio |
0.04 |
|
| Revenue/Share |
7.15 |
| Earnings/Share |
0.39 |
| Book Value/Share |
10.46 |
| Dividend Rate |
0.00 |
| Payout Ratio |
0.00% |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 54.0 | 53.6 | 48.4 |
| 2nd Qtr | 51.3 | 57.9 | 49.4 |
| 3rd Qtr | NA | 61.4 | 47.6 |
| 4th Qtr | NA | 56.4 | 47.2 |
| Total | 105.3 | 229.3 | 192.5 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | $0.06 | $0.15 | $0.10 |
| 2nd Qtr | $0.01 | $0.18 | $0.14 |
| 3rd Qtr | NA | $0.22 | $0.06 |
| 4th Qtr | NA | $0.10 | -$0.03 |
| Total | $0.07 | $0.65 | $0.27 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -40% | NA | --- |
| 2nd Qtr | -83% | 20% | 40% |
| 3rd Qtr | NA | 22% | -57% |
| 4th Qtr | NA | -55% | NA |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | -60% | 50% |
| 2nd Qtr | -94% | 29% |
| 3rd Qtr | NA | 267% |
| 4th Qtr | NA | NA |
advertisement
Recent News